Clinical Trial Update: A Randomized Controlled Trial Comparing the Effectiveness of Different Treatment Options for Weight Management After Discontinuation of Semaglutide and Tirzepatide (GLP1 Transition Trial) [Phase 4]

View source ↗

Summary

A Phase 4 randomized trial compares different weight-management strategies after stopping semaglutide or tirzepatide to evaluate which approach best supports we…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight

Drugs mentioned

• Tirzepatide (tirzepatide)
• semaglutide (semaglutide)

Snippet

Sponsor: WW International Inc | Conditions: Obesity, Overweight | Phase 4 | Status: COMPLETED